Ekso Bionics (NASDAQ:EKSO) and Taylor Devices (NASDAQ:TAYD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk.
Volatility and Risk
Ekso Bionics has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Comparatively, Taylor Devices has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500.
Earnings and Valuation
This table compares Ekso Bionics and Taylor Devices’ gross revenue, earnings per share and valuation.
Taylor Devices has higher revenue and earnings than Ekso Bionics.
This is a breakdown of recent recommendations for Ekso Bionics and Taylor Devices, as provided by MarketBeat.com.
Institutional & Insider Ownership
38.4% of Ekso Bionics shares are held by institutional investors. Comparatively, 30.1% of Taylor Devices shares are held by institutional investors. 35.5% of Ekso Bionics shares are held by company insiders. Comparatively, 4.8% of Taylor Devices shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
This table compares Ekso Bionics and Taylor Devices’ net margins, return on equity and return on assets.
Taylor Devices beats Ekso Bionics on 7 of the 10 factors compared between the two stocks.
About Ekso Bionics
Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, and lower limb paralysis or weakness. The company's Ekso device is primarily used in a clinic or rehabilitation setting. It also performs research and development work on human exoskeletons and related technologies. The company has a license agreement with Lockheed Martin Corporation, Regents of the University of California, and Garrett Brown, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California.
About Taylor Devices
Taylor Devices, Inc. designs, develops, manufactures, and markets shock absorption, rate control, and energy storage devices for use in machinery, equipment, and structures in North America, Asia, and internationally. The company's products include seismic dampers that are designed to ameliorate the effects of earthquake tremors on structures; Fluidicshoks, which are compact shock absorbers primarily used in defense, aerospace, and commercial industries; and crane and industrial buffers, which are larger versions of the Fluidicshoks for industrial application on cranes, ships, container ships, railroad cars, truck docks, ladle and ingot cars, ore trolleys, and car stops. Its products also comprise self-adjusting shock absorbers that include versions of Fluidicshoks, and crane and industrial buffers, which automatically adjust to various impact conditions and are designed for high cycle application primarily in the heavy industry; liquid die springs that are used as component parts of machinery and equipment used in the manufacture of tools and dies; vibration dampers, which are primarily used by aerospace and defense industries to control the response of electronics and optical systems subjected to air, ship, or spacecraft vibration; machined springs used in the aerospace applications; and custom actuators for special military and aerospace applications. The company markets its products through a network of sales representatives and distributors. Taylor Devices, Inc. was founded in 1955 and is headquartered in North Tonawanda, New York.